Kura Oncology, Inc. Income Statement
KURA / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Kura Oncology, Inc. reported $67M in revenue and $279M in net loss for FY2025. Revenue increased 25.2% from FY2024 to FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67.5M | $53.9M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| SG&A Expense | $120.0M | $77.1M | $50.6M | $47.1M | $46.5M | $31.5M | $19.7M | $16.1M | $9.7M | - | - | $165.0K | $22.7K | $22.3K | $23.4K |
| R&D Expense | $251.1M | $170.0M | $115.2M | $92.8M | $84.7M | $60.4M | $47.8M | $46.8M | $26.4M | - | - | - | - | - | - |
| Operating Income | -$303.6M | -$193.2M | -$165.8M | -$139.9M | - | - | - | - | - | - | - | -$180.7K | -$22.7K | -$22.3K | -$23.4K |
| Interest Expense | - | - | $1.5M | $229.0K | $414.0K | $578.0K | $580.0K | $970.0K | $888.0K | $577.0K | $42.0K | $24.0K | $5.9K | $5.0K | $3.6K |
| Income Tax | $297.0K | $2.0M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - | - | - | - |
| Net Income | -$278.7M | -$174.0M | -$152.6M | -$135.8M | -$130.5M | -$89.6M | -$63.1M | -$60.4M | -$35.4M | -$27.6M | -$22.6M | -$204.7K | -$28.6K | -$27.3K | -$27.0K |
| EPS (Basic) | -$2.08 | -$2.03 | -$2.08 | -$2.03 | -$1.97 | -$1.69 | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$2.08 | -$2.03 | -$2.08 | -$2.03 | -$1.97 | -$1.69 | - | - | - | - | - | - | - | - | - |
| Shares Outstanding | 78.2M | 74.3M | 73.2M | 67.0M | 66.4M | 53.1M | 41.9M | 35.2M | 23.2M | 18.7M | 9.9M | 4.9M | 5.0M | 5.0M | 5.0M |
| Operating Margin | -449.9% | -358.6% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Profit Margin | -413.0% | -322.9% | - | - | - | - | - | - | - | - | - | - | - | - | - |